Search results for Biopharma

Rethinking the path to IND: How an integrated, global approach can accelerate biologics development

Thermo Fisher’s future US-based option for biologic and sterile fill-finish manufacturing will help to alleviate capacity bottlenecks globally.

Top 10 Pharmaceutical Sectors Set to Boom (2026–2031)

The pharmaceutical industry is entering a new era of hyper-growth, specifically within subsectors powered by next-generation biological and genetic engineering. These fields are cu...

Biologics CDMO Market 2026: Who’s Winning, What’s Driving Growth, and Should You Buy the Report?

The Biologics CDMO Market is rapidly transforming the pharmaceutical and biotech landscape. As drug developers increasingly outsource complex biologics manufacturing, Contract Deve...

<![CDATA[The Evolving Relationship Between FDA and Biotech]]>

<![CDATA[Pharma M&A Roundup: Bayer to Acquire Perfuse Therapeutics, Madrigal Enters Licensing Agreement for ARO-P...

<![CDATA[Pharma Finance Roundup: Platform Innovation Drives Biotech Investment Across Oncology and Immunology]]>

<![CDATA[Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals ]]>

What are some of the top biopharmas looking for in a job applicant?

NIBRT’s annual fair saw some of the biopharmaceutical sector's key players share their experiences and expertise with potential future employees. Read more: What are some of the t...

<![CDATA[The Relationship Between the Capital Markets and Biotech?]]>

Japanese Pharma Companies Turning to CDMOs Earlier in Product Life Cycle

The bottleneck isn’t discovery anymore. It’s execution. In peptides, programs are running into challenges around analytical complexity, scaleup, and the availability of key raw mat...

<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Ther...

<![CDATA[Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal]]>

<![CDATA[Model Examples]]>

<![CDATA[BioNTech Releases First Quarter Results for 2026 ]]>

Achieving Effective Manufacturing Scaleup for Clinical and Commercial Success

Effective partnering between pharma and manufacturing as well as growing pains and lessons learned in scaling

Five Arrows-backed BioPhorum scoops up PharmaX Solutions

BioPhorum is a London-based biopharma consultant. The post Five Arrows-backed BioPhorum scoops up PharmaX Solutions appeared first on PE Hub.

CPC Biotech Launched to Offer a Fluid Management Component Portfolio

CPC Biotech’s solutions support a range of applications in bioprocessing operations, spanning the upstream and downstream biologic drug manufacturing process, as well as cell and g...

Why a Verified Biopharma Intelligence Network Is Quietly Becoming the Credential Itself

<![CDATA[Beyond the Molecule: The New Competitive Battlefield in Oncology]]>

This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’

Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnolo...

<![CDATA[Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand St...

<![CDATA[The Biotech Industry’s Relationship with Real-Time Data: Q&A with Dr. Richard Graham]]>

<![CDATA[The Evolving Biopharma Regulatory Landscape: Q&A with Harpreet Singh, MD]]>

US Investments Intended To Take Indian Pharma Up The Value Chain: Interview

This is the first time such huge investments are being made. The Indian pharmaceutical industry has grown from small companies into multinational corporations. Out of the top 20 gl...